Teleflex Files Form 8-K on March 27, 2026: Teleflex filed a Form 8‑K on Mar 27, 2026 (Investing.com). SEC rules require 4 business days for 8‑K filings; institutional investors should read EDGAR exhibits for detail. 👈 Read full analysis #Teleflex #Form8K #SECfilings #Investing #FinancialDisclosure
Teleflex Rejects Irenic on Buyout Availability: Teleflex disputes Irenic's Mar 27, 2026 claim that it wasn't open to buyout offers; Seeking Alpha reported the exchange on Mar 27, 2026 and activists… 👈 Read full analysis #Teleflex #Irenic #Buyout #MergersAndAcquisitions #ActivistInvesting
Pomerantz Law Firm Launches Investigation into Teleflex Incorporated for Investor Claims #USA #New_York #Securities_Fraud #Pomerantz_LLP #Teleflex
Teleflex sells acute care and urology businesses for $2.03 billion. Learn how its Board of Directors authorizes new $1 billion share repurchase program: buff.ly/vEHpzZS #todaysmedicaldevelopmentsmag #tmdmag #medtech #manufacturing #teleflex
Pomerantz Law Firm Launches Investigation for Teleflex Investors Following Executive Departures #USA #New_York #Pomerantz_LLP #Teleflex #TFX
Rosen Law Firm's Class Action Investigation into Teleflex's Securities Misrepresentation Claims #USA #New_York #Securities_Fraud #Rosen_Law_Firm #Teleflex
Rosen Law Firm Investigates Potential Securities Claims for Teleflex Investors #Class_Action #Rosen_Law_Firm #無し #Teleflex
Rosen Law Firm Investigates Teleflex Inc. for Class Action Securities Claims #United_States #New_York #Rosen_Law #Teleflex #TFX
Teleflex Incorporated Faces Class Action Investigation Amid Claims of Misleading Business Practices #USA #New_York #Securities #Rosen_Law_Firm #Teleflex
Investor Alert: Pomerantz Law Firm Probes Teleflex Securities Fraud Claims #United_States #New_York #Securities_Fraud #Pomerantz_LLP #Teleflex
Pomerantz Law Firm Launches Investigation Into Teleflex Incorporation'S Recent Activities Affecting Investors #United_States #New_York #Securities_Fraud #Pomerantz #Teleflex
Teleflex will acquire BIOTRONIK’s Vascular Intervention business. Learn how this will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices: buff.ly/i9C1gbk #tmdmag #medtech #teleflex #biotronik